Criticaleye recently caught up with Abbas Hussain, President, Emerging Markets at GlaxoSmithKline, to discuss the state of emerging markets and the initial stages of GSK’s low-cost drug plan, a revolutionary scheme set to change the face of the pharmaceutical industry.
Read, watch & listen to some of the latest thought leadership from our Community.
IPEM Allocation and Fundraising Trend Report 2027
The private markets industry is entering a new investment cycle, with LPs increasingly focused on diversification, alpha generation and demonstrable value creation, as return expectations come under pressure. This repor...
HR Shared Services Trends Report 2026
The world of HR is evolving rapidly, as organisations look to improve efficiency, embrace AI and enhance the employee experience. This report by LACE Partners looks into how organisations can balance artificial intel...
BLOG | Human Capital at the Crossroad
Artificial intelligence, geopolitical instability and sustained economic uncertainty are reshaping the human capital agenda and placing new demands on Boards. Workforce models, skills requirements, talent strategies ...
Displaying 1 to 3 of 209
We use cookies to improve your experience. By using our site, you agree to our use of cookies.
